On Jun 27, 2018 Viveve Medical Inc (NASDAQ:VIVE) Sellers Rose Their Shorts By 5.89%

June 27, 2018 - By Arturo Altman

Viveve Medical Inc (NASDAQ:VIVE) recorded an increase of 5.89% in short interest. FINRA published in June VIVE’s total 3.33M short interest. The up change of 5.89% from 3.14M shares was reported. Viveve Medical Inc (NASDAQ:VIVE) has 281,800 shares average volume. It’ll cost 12 days for VIVE to restore its former position. Viveve Medical Inc float short is 37.34%.

Ticker’s shares touched $2.75 during the last trading session after 0.72% change.Viveve Medical, Inc. has volume of 152,786 shares. Since June 27, 2017 VIVE has declined 65.48% and is downtrending. VIVE underperformed by 78.05% the S&P 500.

Viveve Medical, Inc. designs, develops, makes, and markets medical devices for the non-invasive treatment of vaginal laxity.The company has $85.99 million market cap. The firm offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories.Currently it has negative earnings. It markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.

For more Viveve Medical, Inc. (NASDAQ:VIVE) news brought out briefly go to: Streetinsider.com, Seekingalpha.com, Globenewswire.com, Globenewswire.com or Benzinga.com. The titles are as follows: “After-Hours Stock Movers 06/18: (GEVO) (VIVE) (CL) Higher; (PAGS) (TELL) (DEA) Lower (more…)” brought out on June 18, 2018, “Viveve Medical’s CMRF technology shows positive effect in women with SUI; shares up 12% after hours” on June 18, 2018, “Viveve to Present at Jefferies Global Healthcare Conference” with a publish date: May 29, 2018, “Viveve Announces Settlement of Patent Infringement Litigation with Thermi” and the last “5 Stocks Moving In Monday’s After-Hours Session” with publication date: June 19, 2018.

Viveve Medical, Inc. (NASDAQ:VIVE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: